ArticleBiomarker insights2018

Development of a Novel Proteomic Risk-Classifier for Prognostication of Patients With Early-Stage Hormone Receptor-Positive Breast Cancer.

Charusheila Ramkumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.